Search Results - "Mark, Margery H."

Depression in Parkinson's Disease: Symptom Improvement and Residual Symptoms After Acute Pharmacologic Management by Dobkin, Roseanne DeFronzo, Ph.D, Menza, Matthew, M.D, Bienfait, Karina L., Ph.D, Gara, Michael, Ph.D, Marin, Humberto, M.D, Mark, Margery H., M.D, Dicke, Allison, B.A, Friedman, Jill, Ph.D

“…Objective Parkinson's disease (PD) is frequently complicated by depression and there is a paucity of controlled research that can inform the management of this…”
Get full text

Cognitive-Behavioral Therapy for Depression in Parkinson's Disease: A Randomized, Controlled Trial by Dobkin, Roseanne D., Menza, Matthew, Allen, Lesley A., Gara, Michael A., Mark, Margery H., Tiu, Jade, Bienfait, Karina L., Friedman, Jill

“…Depression scores declined more for depressed patients with Parkinson's disease who received 10 weeks of CBT plus clinical monitoring than for those who…”
Get full text

The Role of Inflammatory Cytokines in Cognition and Other Non-Motor Symptoms of Parkinson’s Disease by Menza, Matthew, M.D, DeFronzo Dobkin, Roseanne, Ph.D, Marin, Humberto, M.D, Mark, Margery H., M.D, Gara, Michael, Ph.D, Bienfait, Karina, Ph.D, Dicke, Allison, B.A, Kusnekov, Alex, Ph.D

“…Background Parkinson’s disease (PD) affects patients’ lives with more than just physical impairment. Many of the non-motor aspects of PD, such as cognitive…”
Get full text

The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease by Menza, Matthew, Dobkin, Roseanne DeFronzo, Marin, Humberto, Mark, Margery H., Gara, Michael, Buyske, Steven, Bienfait, Karina, Dicke, Allison

“…Parkinson's disease (PD) is a common neurodegenerative disease affecting up to one million individuals in the United States. Depression is found in 40 to 50%…”
Get full text

Predictors of Treatment Response to Cognitive-Behavioral Therapy for Depression in Parkinson's Disease by Dobkin, Roseanne D, Rubino, Jade Tiu, Allen, Lesley A, Friedman, Jill, Gara, Michael A, Mark, Margery H, Menza, Matthew

“…Objective: The purpose of this study was to examine predictors of treatment response to cognitive-behavioral therapy (CBT) for depression in Parkinson's…”
Get full text

Psychogenic parkinsonism: clinical spectrum and diagnosis by Sage, Jacob I, Mark, Margery H

“…Patients with psychogenic parkinsonism (PP), like those with Parkinson's disease (PD), may have tremor, bradykinesia, rigidity, and gait disturbances. Unusual…”
Get more information

Telephone-Based Cognitive–Behavioral Therapy for Depression in Parkinson Disease by Dobkin, Roseanne D., Menza, Matthew, Allen, Lesley A., Tiu, Jade, Friedman, Jill, Bienfait, Karina L., Gara, Michael A., Mark, Margery H.

“…Background: Although face-to-face cognitive–behavioral therapy (CBT) was found to be beneficial for the treatment of depression in Parkinson disease (dPD) in a…”
Get full text

A long-term study of istradefylline in subjects with fluctuating Parkinson's disease by Factor, Stewart, Mark, Margery H, Watts, Ray, Struck, Lynn, Mori, Akihisa, Ballerini, Rocco, Sussman, Neil M

Get full text

Neuropsychological Outcomes After Psychosocial Intervention for Depression in Parkinson’s Disease by Dobkin, Roseanne D, Tröster, Alexander I, Rubino, Jade Tiu, Allen, Lesley A, Gara, Michael A, Mark, Margery H, Menza, Matthew

“…The authors describe neuropsychological outcomes in people with Parkinson’s disease after their participation in an NIH-sponsored, randomized controlled trial…”
Get full text

Impulsive smoking in a patient with Parkinson’s disease treated with dopamine agonists by Bienfait, Karina L, Menza, Matthew, Mark, Margery H, Dobkin, Roseanne D

“…Abstract Impulse control disorders, including pathological gambling, binge eating, compulsive shopping and hypersexual behaviors, have frequently been reported…”
Get full text

Fibrillization of α-synuclein and tau in familial Parkinson's disease caused by the A53T α-synuclein mutation by Kotzbauer, Paul T., Giasson, Benoit I., Kravitz, Alexxai V., Golbe, Lawrence I., Mark, Margery H., Trojanowski, John Q., Lee, Virginia M.-Y.

“…Mutations in the α-synuclein ( α-syn) gene are responsible for a rare familial parkinsonism syndrome, a finding that has led to extensive characterization of…”
Get full text

The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study by Latourelle, Jeanne C, Sun, Mei, Lew, Mark F, Suchowersky, Oksana, Klein, Christine, Golbe, Lawrence I, Mark, Margery H, Growdon, John H, Wooten, G Frederick, Watts, Ray L, Guttman, Mark, Racette, Brad A, Perlmutter, Joel S, Ahmed, Anwar, Shill, Holly A, Singer, Carlos, Goldwurm, Stefano, Pezzoli, Gianni, Zini, Michela, Saint-Hilaire, Marie H, Hendricks, Audrey E, Williamson, Sally, Nagle, Michael W, Wilk, Jemma B, Massood, Tiffany, Huskey, Karen W, Laramie, Jason M, DeStefano, Anita L, Baker, Kenneth B, Itin, Ilia, Litvan, Irene, Nicholson, Garth, Corbett, Alastair, Nance, Martha, Drasby, Edward, Isaacson, Stuart, Burn, David J, Chinnery, Patrick F, Pramstaller, Peter P, Al-hinti, Jomana, Moller, Anette T, Ostergaard, Karen, Sherman, Scott J, Roxburgh, Richard, Snow, Barry, Slevin, John T, Cambi, Franca, Gusella, James F, Myers, Richard H

“…We report age-dependent penetrance estimates for leucine-rich repeat kinase 2 (LRRK2)-related Parkinson's disease (PD) in a large sample of familial PD. The…”
Get full text

The Impact of Antidepressant Treatment on Cognitive Functioning in Depressed Patients with Parkinson's Disease by Dobkin, Roseanne DeFronzo, Menza, Matthew, Bienfait, Karina L, Gara, Michael, Marin, Humberto, Mark, Margery H, Dicke, Allison, Tröster, Alexander

“…Depression is associated with more rapid cognitive decline in Parkinson's disease. The goal of this study was to examine the impact of the acute (8-week) and…”
Get full text

Diversity of pathological features other than Lewy bodies in familial Parkinson's disease due to SNCA mutations by Fujishiro, Hiroshige, Imamura, Akiko Yamashita, Lin, Wen-Lang, Uchikado, Hirotake, Mark, Margery H, Golbe, Lawrence I, Markopoulou, Katerina, Wszolek, Zbigniew K, Dickson, Dennis W

“…The clinical features of the genetically determined forms of familial Parkinson's disease (PD) have been described in multiple reports, but there have been few…”
Get full text

Replication of association between ELAVL4 and Parkinson disease: the GenePD study by DeStefano, Anita L., Latourelle, Jeanne, Lew, Mark F., Suchowersky, Oksana, Klein, Christine, Golbe, Lawrence I., Mark, Margery H., Growdon, John H., Wooten, G. Fredrick, Watts, Ray, Guttman, Mark, Racette, Brad A., Perlmutter, Joel S., Marlor, Lynn, Shill, Holly A., Singer, Carlos, Goldwurm, Stefano, Pezzoli, Gianni, Saint-Hilaire, Marie H., Hendricks, Audrey E., Gower, Adam, Williamson, Sally, Nagle, Michael W., Wilk, Jemma B., Massood, Tiffany, Huskey, Karen W., Baker, Kenneth B., Itin, Ilia, Litvan, Irene, Nicholson, Garth, Corbett, Alastair, Nance, Martha, Drasby, Edward, Isaacson, Stuart, Burn, David J., Chinnery, Patrick F., Pramstaller, Peter P., Al-hinti, Jomana, Moller, Anette T., Ostergaard, Karen, Sherman, Scott J., Roxburgh, Richard, Snow, Barry, Slevin, John T., Cambi, Franca, Gusella, James F., Myers, Richard H.

“…Genetic variants in embryonic lethal, abnormal vision, Drosophila-like 4 ( ELAVL4 ) have been reported to be associated with onset age of Parkinson disease…”
Get full text

The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson's disease by Dobkin, Roseanne DeFronzo, Menza, Matthew, Bienfait, Karina L, Gara, Michael, Marin, Humberto, Mark, Margery H, Dicke, Allison, Tröster, Alexander

“…Depression is associated with more rapid cognitive decline in Parkinson's disease. The goal of this study was to examine the impact of the acute (8-week) and…”
Get full text

PARK3 Influences Age at Onset in Parkinson Disease: A Genome Scan in the GenePD Study by DeStefano, Anita L., Lew, Mark F., Golbe, Lawrence I., Mark, Margery H., Lazzarini, Alice M., Guttman, Mark, Montgomery, Erwin, Waters, Cheryl H., Singer, Carlos, Watts, Ray L., Currie, Lillian J., Wooten, G. Frederick, Maher, Nancy E., Wilk, Jemma B., Sullivan, Kristin M., Slater, Karen M., Saint-Hilaire, Marie H., Feldman, Robert G., Suchowersky, Oksana, Lafontaine, Anne-Louise, Labelle, Nancy, Growdon, John H., Vieregge, Peter, Pramstaller, Peter P., Klein, Christine, Hubble, Jean P., Reider, Carson R., Stacy, Mark, MacDonald, Marcy E., Gusella, James F., Myers, Richard H.

“…Parkinson disease (PD) is a late-onset neurodegenerative disorder. The mean age at onset is 61 years, but the disease can range from juvenile cases to cases in…”
Get full text

The Role of Inflammatory Cytokines in Cognition and Other Non-Motor Symptoms of Parkinson's Disease by Menza, M., Dobkin, R. D., Marin, H., Mark, M. H., Gara, M., Bienfait, K., Dicke, A., Kusnekov, A.

“…BACKGROUNDParkinson's disease (PD) affects patients' lives with more than just physical impairment. Many of the non-motor aspects of PD, such as cognitive…”
Get full text

The tau A0 allele in Parkinson's disease by Golbe, Lawrence I., Lazzarini, Alice M., Spychala, John R., Johnson, William G., Stenroos, Edward S., Mark, Margery H., Sage, Jacob I.

“…Parkinson's disease (PD) is primarily an α‐synucle‐ inopathy, rather than a tauopathy, but there is evidence for an indirect association of tau with the…”
Get full text

Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD study by McNicoll, Christopher F., Latourelle, Jeanne C., MacDonald, Marcy E., Lew, Mark F., Suchowersky, Oksana, Klein, Christine, Golbe, Lawrence I., Mark, Margery H., Growdon, John H., Wooten, G. Frederick, Watts, Ray L., Guttman, Mark, Racette, Brad A., Perlmutter, Joel S., Ahmed, Anwar, Shill, Holly A., Singer, Carlos, Saint-Hilaire, Marie H., Massood, Tiffany, Huskey, Karen W., DeStefano, Anita L., Gillis, Tammy, Mysore, Jayalakshmi, Goldwurm, Stefano, Pezzoli, Gianni, Baker, Kenneth B., Itin, Ilia, Litvan, Irene, Nicholson, Garth, Corbett, Alastair, Nance, Martha, Drasby, Edward, Isaacson, Stuart, Burn, David J., Chinnery, Patrick F., Pramstaller, Peter P., Al-Hinti, Jomana, Moller, Anette T., Ostergaard, Karen, Sherman, Scott J., Roxburgh, Richard, Snow, Barry, Slevin, John T., Cambi, Franca, Gusella, James F., Myers, Richard H.

“…The ATP/ADP ratio reflects mitochondrial function and has been reported to be influenced by the size of the Huntington disease gene (HD) repeat. Impaired…”
Get full text